 |
 |
 |
||
 |
December 4, 2008 |  |
||
 |
 |
|||
 |
Predictive Health Symposium Links Molecular Studies and Population Health The fourth annual Emory/Georgia Tech Predictive Health Symposium, Dec. 15-16, features more than 20 speakers from academia, government, and industry discussing the integration of biology, behavior and environment, including genetics, pharmacogenomics, metabolomics, health care delivery and economics, prospective medicine, and public health. View the agenda and register . . . |
|||
|
|
|||
 |
Rapid Screening Test Detects Early Alzheimer's Disease A new screening test that combines cognitive screening with a functional activities questionnaire will allow physicians to correctly classify early stages of cognitive impairment. Early detection is key to maintaining a good quality of life for as long as possible. Read more . . . |
|||
|
|
|||
Emory-S. Africa Drug Training Partnership Creates New Model for Entrepreneurs Chemist Dennis Liotta, whose drug discovery successes are among the most widely prescribed HIV therapies worldwide, is translating his skills to an ambitious Emory partnership with South Africa. Supported by the Emory Global Health Institute, the training program is transferring drug discovery expertise to an area of the world that needs it most. Read more . . . |
||||
|
|
|||
 |
Researchers Take Stock After a Promising HIV Vaccine Falters Researchers at the Emory Vaccine Center's Hope Clinic were primary participants in a national clinical trial of a promising HIV vaccine developed by Merck. Since the trial was halted abruptly last year, scientists have been moving forward using important lessons learned. Read more. . . |
|||
|
|
|||
 Ernest Garcia, PhD |
|
|||
 |
 |
|||
